Synthesis and study of anti-HIV-1 RT activity of 5-benzoyl-4-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one derivatives. 2017

Subhash Chander, and Cheng-Run Tang, and Helmi Mohammed Al-Maqtari, and Joazaizulfazli Jamalis, and Ashok Penta, and Taibi Ben Hadda, and Hasnah Mohd Sirat, and Yong-Tang Zheng, and Murugesan Sankaranarayanan
Medicinal Chemistry Research Laboratory, Department of Pharmacy, Birla Institute of Technology & Science, Pilani 333031, Rajasthan, India.

In the present study, a series of fourteen 5-benzoyl-4-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one derivatives were designed, synthesized and characterized by appropriate spectral analysis. Further, titled compounds were in-vitro screened against wild HIV-1 RT enzyme using ELISA based colorimetric assay, in which four compounds significantly inhibited the RT activity with IC50≤25µM. Moreover, two significantly active compounds of the series, A10 and A11 exhibited IC50 values 8.62 and 6.87µM respectively, during the in-vitro assay. Structure Activity Relationship (SAR) studies were performed for the synthesized compounds in order to estimate the effect of substitution pattern on the RT inhibitory potency. The cytotoxicity of the synthesized compounds was evaluated against T lymphocytes. Further, putative binding modes of the significantly active (A11) and the least active (A4) compounds with wild HIV-1 RT were also investigated using docking studies.

UI MeSH Term Description Entries
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

Subhash Chander, and Cheng-Run Tang, and Helmi Mohammed Al-Maqtari, and Joazaizulfazli Jamalis, and Ashok Penta, and Taibi Ben Hadda, and Hasnah Mohd Sirat, and Yong-Tang Zheng, and Murugesan Sankaranarayanan
November 1999, Bioorganic & medicinal chemistry,
Subhash Chander, and Cheng-Run Tang, and Helmi Mohammed Al-Maqtari, and Joazaizulfazli Jamalis, and Ashok Penta, and Taibi Ben Hadda, and Hasnah Mohd Sirat, and Yong-Tang Zheng, and Murugesan Sankaranarayanan
January 1996, Acta poloniae pharmaceutica,
Subhash Chander, and Cheng-Run Tang, and Helmi Mohammed Al-Maqtari, and Joazaizulfazli Jamalis, and Ashok Penta, and Taibi Ben Hadda, and Hasnah Mohd Sirat, and Yong-Tang Zheng, and Murugesan Sankaranarayanan
March 1995, Journal of medicinal chemistry,
Subhash Chander, and Cheng-Run Tang, and Helmi Mohammed Al-Maqtari, and Joazaizulfazli Jamalis, and Ashok Penta, and Taibi Ben Hadda, and Hasnah Mohd Sirat, and Yong-Tang Zheng, and Murugesan Sankaranarayanan
January 1998, Acta poloniae pharmaceutica,
Subhash Chander, and Cheng-Run Tang, and Helmi Mohammed Al-Maqtari, and Joazaizulfazli Jamalis, and Ashok Penta, and Taibi Ben Hadda, and Hasnah Mohd Sirat, and Yong-Tang Zheng, and Murugesan Sankaranarayanan
May 1964, Journal of medicinal chemistry,
Subhash Chander, and Cheng-Run Tang, and Helmi Mohammed Al-Maqtari, and Joazaizulfazli Jamalis, and Ashok Penta, and Taibi Ben Hadda, and Hasnah Mohd Sirat, and Yong-Tang Zheng, and Murugesan Sankaranarayanan
February 1991, Journal of medicinal chemistry,
Subhash Chander, and Cheng-Run Tang, and Helmi Mohammed Al-Maqtari, and Joazaizulfazli Jamalis, and Ashok Penta, and Taibi Ben Hadda, and Hasnah Mohd Sirat, and Yong-Tang Zheng, and Murugesan Sankaranarayanan
March 1995, Journal of medicinal chemistry,
Subhash Chander, and Cheng-Run Tang, and Helmi Mohammed Al-Maqtari, and Joazaizulfazli Jamalis, and Ashok Penta, and Taibi Ben Hadda, and Hasnah Mohd Sirat, and Yong-Tang Zheng, and Murugesan Sankaranarayanan
April 2000, Acta crystallographica. Section C, Crystal structure communications,
Subhash Chander, and Cheng-Run Tang, and Helmi Mohammed Al-Maqtari, and Joazaizulfazli Jamalis, and Ashok Penta, and Taibi Ben Hadda, and Hasnah Mohd Sirat, and Yong-Tang Zheng, and Murugesan Sankaranarayanan
June 1977, Journal of medicinal chemistry,
Subhash Chander, and Cheng-Run Tang, and Helmi Mohammed Al-Maqtari, and Joazaizulfazli Jamalis, and Ashok Penta, and Taibi Ben Hadda, and Hasnah Mohd Sirat, and Yong-Tang Zheng, and Murugesan Sankaranarayanan
January 2018, CNS & neurological disorders drug targets,
Copied contents to your clipboard!